Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Waisman Center investigator David Gamm, MD, PhD, and Waisman affiliate Kris Saha, PhD, have published a proof-of-concept method to correct Best disease – an inherited form of macular degeneration that causes blindness, and that is currently untreatable. To read the article, click here.
A big congratulations to researcher Kim Edwards and Waisman investigator David Gamm, MD, PhD, on winning the inaugural Randy Wheelock Research Award. Gamm is also an associate professor of ophthalmology and visual science as well as the director of the McPherson Eye Research Institute.
A recent story on Channel 3000 highlights the efforts by the family of Kenzi Valentyn to raise money for vision research in their daughter’s name. Waisman investigator David Gamm focuses on using stem cells to fight vision diseases, including retinitis pigmentosa. To learn more about Kenzi’s story and David Gamm’s research, please visit: ‘This can be …
David Gamm, director of the McPherson Eye Research Institute, and Forward Bio Institute director Bill Murphy explain how stem cell scientists at UW–Madison are working with industry to put scientific breakthroughs on the path to helping patients.
To mark the 20th anniversary of the stem cell discovery at UW–Madison, the Wisconsin State Journal featured a series of stories on stem cell research, highlighting the work of Waisman Center investigators David Gamm, Anita Bhattacharyya, Su-Chun Zhang, affiliate Randall Ashton, as well as Waisman Biomanufacturing. Researchers at the Waisman Center use stem cells— undifferentiated …
A story in the Milwaukee Journal Sentinel reflects on the history of stem cells and its future direction. Two decades after the first stem cell breakthrough, the promising biological discovery is beginning to take steps toward clinical trials. Waisman Center investigator David Gamm, who researches stem cell therapies for diseases of the eye, reflects on …
Waisman Center investigator David Gamm, MD, PhD, and affiliate Krishanu Saha, PhD, are part of a team of scientists at the University of Wisconsin- Madison who were recently granted a major award from the National Institute of Health’s Somatic Cell Genome Editing Consortium (SCGE). This award will support research focused on developing quality control methods …
Inherited and acquired degenerative diseases of the retina are a significant cause of incurable vision loss worldwide. David Gamm, MD, PhD, utilizes stem cell technology to test ways to preserve or restore vision in people afflicted by blinding disorders. Gamm and 160 researchers at the Waisman Center and the McPherson Eye Research Institute work to develop treatments for …
When Madison attorney David Walsh learned 17 years ago that his sons have a genetic disorder that causes blindness, he went into action mode.
But the specks in the Petri dishes were the result of years of research in the laboratory of David Gamm, an ophthalmologist at the UW’s Waisman Center. And as members of the Reese family carefully cradled the dishes, they held the future of their descendants’ eyesight in their hands.
